The effects of terlipressin on regional hemodynamics and kidney function in experimental hyperdynamic sepsis

PLoS ONE

Volumn 7, Issue 2, 2012, Pages

  Ishikawa, Ken ^a,b   Wan, Li ^a,b   Calzavacca, Paolo ^a,b   Bellomo, Rinaldo ^b,c   Bailey, Michael ^c   May, Clive N ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b AUSTIN HEALTH   (Australia)

^c MONASH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CREATININE; FLUNIXIN MEGLUMINE; GENTAMICIN; LACTIC ACID; TERLIPRESSIN; THIOPENTAL; DRUG DERIVATIVE; LYPRESSIN; VASOCONSTRICTOR AGENT;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY CIRCUMFLEX BRANCH; CORONARY RISK; CREATININE CLEARANCE; CROSSOVER PROCEDURE; DRUG EFFECT; DRUG MECHANISM; DRUG RESPONSE; ESCHERICHIA COLI; EWE; EXPERIMENTAL HYPERDYNAMIC SEPSIS; FEMALE; ILIAC ARTERY; KIDNEY FUNCTION; LACTATE BLOOD LEVEL; LIVER CIRRHOSIS; MEAN ARTERIAL PRESSURE; MESENTERY BLOOD FLOW; NONHUMAN; PULMONARY ARTERY; RANDOMIZED CONTROLLED TRIAL; RENAL ARTERY; SEPSIS; SINGLE DRUG DOSE; SUPERIOR MESENTERIC ARTERY; URINE VOLUME; ANIMAL; BLOOD FLOW; ESCHERICHIA COLI INFECTION; HEMODYNAMICS; KIDNEY; MICROBIOLOGY; PATHOGENICITY; PATHOPHYSIOLOGY; SEPTIC SHOCK; SHEEP; VASCULARIZATION;

ANIMALIA; ESCHERICHIA COLI;

ANIMALS; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FEMALE; HEMODYNAMICS; KIDNEY; LYPRESSIN; REGIONAL BLOOD FLOW; SHEEP; SHOCK, SEPTIC; VASOCONSTRICTOR AGENTS;

EID: 84857067653     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0029693     Document Type: Article

References (39)

1. Martin GS, Mannino DM, Eaton S, Moss M, (2003) The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 348: 1546-1554.
2. Dellinger RP, Levy MM, Carlet JM, Bion J, Parker MM, et al. (2008) Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med 36: 296-327.
3. Holmes CL, Walley KR, (2009) Vasoactive drugs for vasodilatory shock in ICU. Curr Opin Crit Care 15: 398-402.
4. Leone M, Albanese J, Delmas A, Chaabane W, Garnier F, et al. (2004) Terlipressin in catecholamine-resistant septic shock patients. Shock 22: 314-319.
5. Jing L, Wu Q, Wang F, (2007) Glutamine induces heat-shock protein and protects against Escherichia coli lipopolysaccharide-induced vascular hyporeactivity in rats. Crit Care 11: R34.
6. Delmas A, Leone M, Rousseau S, Albanese J, Martin C, (2005) Clinical review: Vasopressin and terlipressin in septic shock patients. Crit Care 9: 212-222.
7. Russell JA, Walley KR, Singer J, Gordon AC, Hebert PC, et al. (2008) Vasopressin versus norepinephrine infusion in patients with septic shock. N Engl J Med 358: 877-887.
8. Gordon AC, Russell JA, Walley KR, Singer J, Ayers D, et al. (2009) The effects of vasopressin on acute kidney injury in septic shock. Intensive Care Med 36: 83-91.
9. Rajekar H, Chawla Y, (2011) Terlipressin in hepatorenal syndrome. J Gastroenterol Hepatol 26 (Suppl 1): 109-114.
10. Morelli A, Rocco M, Conti G, Orecchioni A, De Gaetano A, et al. (2004) Effects of terlipressin on systemic and regional haemodynamics in catecholamine-treated hyperkinetic septic shock. Intensive Care Med 30: 597-604.
11. Singer M, (2008) Arginine vasopressin vs. terlipressin in the treatment of shock states. Best Pract Res Clin Anaesthesiol 22: 359-368.
12. Lange M, Ertmer C, Westphal M, (2008) Vasopressin vs. terlipressin in the treatment of cardiovascular failure in sepsis. Intensive Care Med 34: 821-832.
13. Rodriguez-Nunez A, Lopez-Herce J, Gil-Anton J, Hernandez A, Rey C, (2006) Rescue treatment with terlipressin in children with refractory septic shock: a clinical study. Crit Care 10: R20.
14. Nilsson G, Lindblom P, Ohlin M, Berling R, Vernersson E, (1990) Pharmacokinetics of terlipressin after single i.v. doses to healthy volunteers. Drugs Exp Clin Res 16: 307-314.
15. Albanese J, Leone M, Delmas A, Martin C, (2005) Terlipressin or norepinephrine in hyperdynamic septic shock: a prospective, randomized study. Crit Care Med 33: 1897-1902.
16. Morelli A, Ertmer C, Westphal M, (2008) Terlipressin in the treatment of septic shock: the earlier the better? Best Pract Res Clin Anaesthesiol 22: 317-321.
17. Rodriguez-Nunez A, Fernandez-Sanmartin M, Martinon-Torres F, Gonzalez-Alonso N, Martinon-Sanchez JM, (2004) Terlipressin for catecholamine-resistant septic shock in children. Intensive Care Med 30: 477-480.
18. Lange M, Morelli A, Ertmer C, Koehler G, Broking K, et al. (2007) Continuous versus bolus infusion of terlipressin in ovine endotoxemia. Shock 28: 623-629.
19. Umgelter A, Reindl W, Schmid RM, Huber W, (2008) Continuous terlipressin infusion in patients with persistent septic shock and cirrhosis of the liver. Intensive Care Med 34: 390-391.
20. Morelli A, Ertmer C, Rehberg S, Lange M, Orecchioni A, et al. (2009) Continuous terlipressin versus vasopressin infusion in septic shock (TERLIVAP): a randomized, controlled pilot study. Crit Care 13: R130.
21. Michel F, Thomachot L, David M, Nicaise C, Vialet R, et al. (2007) Continuous low-dose infusion of terlipressin as a rescue therapy in meningococcal septic shock. Am J Emerg Med 25: 863 e861-862.
22. Di Giantomasso D, Morimatsu H, Bellomo R, May CN, (2006) Effect of low-dose vasopressin infusion on vital organ blood flow in the conscious normal and septic sheep. Anaesth Intensive Care 34: 427-433.
23. Webb RL, Osborn JW Jr, Cowley AW Jr, (1986) Cardiovascular actions of vasopressin: baroreflex modulation in the conscious rat. Am J Physiol 251: H1244-1251.
24. Asfar P, Pierrot M, Veal N, Moal F, Oberti F, et al. (2003) Low-dose terlipressin improves systemic and splanchnic hemodynamics in fluid-challenged endotoxic shock. Crit Care Med 31: 215-20.
25. Scharte M, Meyer J, Van Aken H, Bone HG, (2001) Hemodynamic effects of terlipressin (a synthetic analog of vasopressin) in healthy and endotoxemic sheep. Crit Care Med 29: 1756-60.
26. Lange M, Morelli A, Ertmer C, Koehler G, Bröking K, et al. (2007) Continuous versus bolus infusion of terlipressin in ovine endotoxemia. Shock 28: 623-9.
27. Bröking K, Lange M, Morelli A, Ertmer C, Aken HV, et al. (2008) Employing dobutamine as a useful agent to reverse the terlipressin-linked impairments in cardiopulmonary hemodynamics and global oxygen transport in healthy and endotoxemic sheep. Shock 29: 71-7.
28. Edwards RM, Trizna W, Kinter LB, (1989) Renal microvascular effects of vasopressin and vasopressin antagonists. Am J Physiol 256: F274-278.
29. Wan L, Langenberg C, Bellomo R, May CN, (2009) Angiotensin II in experimental hyperdynamic sepsis. Crit Care 13: R190.
30. Di Giantomasso D, May CN, Bellomo R, (2003) Norepinephrine and vital organ blood flow during experimental hyperdynamic sepsis. Intensive Care Med 29: 1774-1781.
31. Di Giantomasso D, Bellomo R, May CN, (2005) The haemodynamic and metabolic effects of epinephrine in experimental hyperdynamic septic shock. Intensive Care Med 31: 454-462.
32. Stephan F, Paillard F, (1998) Terlipressin-exacerbated hypokalaemia. Lancet 351: 1249-1250.
33. Escorsell A, Bandi JC, Moitinho E, Feu F, Garcia-Pagan JC, et al. (1997) Time profile of the haemodynamic effects of terlipressin in portal hypertension. J Hepatol 26: 621-627.
34. Morelli A, Tritapepe L, Rocco M, Conti G, Orecchioni A, et al. (2005) Terlipressin versus norepinephrine to counteract anesthesia-induced hypotension in patients treated with renin-angiotensin system inhibitors: effects on systemic and regional hemodynamics. Anesthesiology 102: 12-19.
35. Morelli A, Ertmer C, Pietropaoli P, Westphal M, (2009) Terlipressin: a promising vasoactive agent in hemodynamic support of septic shock. Expert Opin Pharmacother 10: 2569-2575.
36. Krishnagopalan S, Kumar A, Parrillo JE, (2002) Myocardial dysfunction in the patient with sepsis. Curr Opin Crit Care 8: 376-388.
37. Solomon MA, Correa R, Alexander HR, Koev LA, Cobb JP, et al. (1994) Myocardial energy metabolism and morphology in a canine model of sepsis. Am J Physiol 266: H757-768.
38. Medel J, Boccara G, Van de Steen E, Bertrand M, Godet G, et al. (2001) Terlipressin for treating intraoperative hypotension: can it unmask myocardial ischemia? Anesth Analg 93: 53-55.
39. Ryckwaert F, Virsolvy A, Fort A, Murat B, Richard S, et al. (2009) Terlipressin, a provasopressin drug exhibits direct vasoconstrictor properties: consequences on heart perfusion and performance. Crit Care Med 37: 876-881.